BioCentury
ARTICLE | Financial News

Catabasis Pharmaceuticals completes IPO

June 29, 2015 7:00 AM UTC

Catabasis Pharmaceuticals Inc. (NASDAQ:CATB), Cambridge, Mass. Business: Endocrine/Metabolic, Inflammation, Autoimmune Date completed: 2015-06-25 Type: IPO Raised: $60 million Shares: 5 million Price:...